Alzheimer’s disease Pre-Clinical Study Pipeline

Golden Biotechnology Corporation (GBC) was named the winner of the Advance Queensland – Johnson & Johnson Innovation QuickFire Challenge in 2016. GBC authorized Queensland University of Technology (QUT) to operate a pre-clinical test, “Antroquinonol testing in an animal model for Alzheimer’s disease- preventive, therapeutic and biomarker animal studies” and executed Research Services Agreement with QUT in 2017. The studies are expected to complete in 2019Q2.